Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 353
Titolo Tipologia Data di pubblicazione Autori File
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study 01 - Articolo su rivista 2024 Gambacorti-Passerini C. +
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia 01 - Articolo su rivista 2024 Zappaterra, ARapella, AGambacorti-Passerini,CCairoli,R +
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study 01 - Articolo su rivista 2024 Gambacorti-Passerini C. +
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 02 - Intervento a convegno 2024 Crippa, VFontana, DCivettini, IMologni, LPiazza, RGambacorti Passerini, CRamazzotti, D
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 01 - Articolo su rivista 2024 Fontana, DilettaGambacorti-Passerini, CarloPiazza, Rocco +
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study 01 - Articolo su rivista 2024 Antolini, LauraMantegazza, RaffaeleCairoli, RobertoGambacorti Passerini, Carlo +
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients 01 - Articolo su rivista 2024 Zappaterra, AriannaCivettini, IvanPierini, SilviaGambacorti-Passerini, CarloCairoli, Roberto +
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape 01 - Articolo su rivista 2024 Fontana, DZambrotta, GPMPiazza, RGambacorti-Passerini, C +
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 01 - Articolo su rivista 2024 Fontana, DMalighetti, FVilla, MZambon, AGambacorti-Passerini,CMologni, L.
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Idiopathic erythrocytosis: a germline disease? 01 - Articolo su rivista 2024 Elli, E. M.Mauri, M.D’Aliberti, D.Crespiatico, I.Fontana, D.Redaelli, S.Pelucchi, S.Spinelli, S.Manghisi, B.Cavalca, F.Aroldi, A.Ripamonti, A.Palamini, S.Mottadelli, F.Massimino, L.Ramazzotti, D.Cazzaniga, G.Piperno, A.Gambacorti-Passerini, C.Piazza, R. +
CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort 02 - Intervento a convegno 2024 Rindone, GGambacorti Passerini, CBonfanti, PVerga, L +
Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3) 99 - Altro 2023 Gambacorti-Passerini C. +
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 01 - Articolo su rivista 2023 Cairoli R.Gambacorti-Passerini C. +
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 01 - Articolo su rivista 2023 Rindone, GiovanniAroldi, AndreaBossi, ElisaVerga, LuisaZambrotta, GiovanniTarantino, SaraPiazza, RoccoGambacorti-Passerini, Carlo +
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 01 - Articolo su rivista 2023 Civettini, IvanZappaterra, AriannaGranelli, Bianca MariaRindone, GiovanniAroldi, AndreaBonfanti, StefanoColombo, FedericaFedele, MarilenaPerfetti, PaolaTerruzzi, ElisabettaGambacorti-Passerini, CarloRamazzotti, DanieleCavalca, Fabrizio +
Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6) 99 - Altro 2023 Gambacorti-Passerini C. +
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study 01 - Articolo su rivista 2023 Piazza R.Guglielmana V.Colombo F.Antolini L.Gambacorti-Passerini C. +
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study 01 - Articolo su rivista 2023 Gambacorti-Passerini C. +
Mostrati risultati da 1 a 20 di 353
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile